Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Windsor

$14,873.00

Nitric oxide bandage

FY 2015-16

Summary
A market study will be conducted at assess the viability of commercializing a new nitric oxide releasing bandage. It has been established by many studies that low amounts of the gas nitric oxide (NO) generated at the surface of the wound prevents bacterial infections and promotes wound healing. Our technology is a nitric oxide releasing bandage. The active ingredient in this bandage is a metal ion catalyst incorporated into an inexpensive and plentiful biopolymer obtained from shellfish. The biopolymer serves to stabilize the catalyst locking it into the biopolymer matrix thus preventing its leaching into the wound. Once the metal ion-biopolymer composite comes in contact with wounds, it interacts with compounds naturally found in wound fluids converting them to nitric oxide thus preventing infections and accelerating wound healing. This technology is targeted to patients with chronic diseases such as diabetes where wound healing is severely retarded or attenuated resulting in increased chances of infection and long recovery times. The other targeted group is patients suffering from pressure ulcers, especially the aging population whereby the aging process has caused structural changes in the epidermis resulting in slow wound healing. Our technology provides an inexpensive way to incorporate NO-releasing capability to bandages. These bandages will promote wound healing and prevent bacterial infections in target-patient populations decreasing recovery time, minimizing medical complications, lowering healthcare costs and increasing the quality of life of the patients. Global wound care market is growing, with an estimated CAGR of 9.5% during 2011 to 2016. Total revenues from skin ulcer segment in the wound care market are expected to reach $8.74 billion in 2016.
Program
Idea to Innovation
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
478902-2015
Name nom
Mutus, Bulent
Department département
Chemistry and Biochemistry
Organization id
37
Institution établissement
University of Windsor
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
14873
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Partie
1
Nb partie
1
Application title
Nitric oxide bandage
Keyword
NSERC
Application summary
A market study will be conducted at assess the viability of commercializing a new nitric oxide releasing bandage. It has been established by many studies that low amounts of the gas nitric oxide (NO) generated at the surface of the wound prevents bacterial infections and promotes wound healing. Our technology is a nitric oxide releasing bandage. The active ingredient in this bandage is a metal ion catalyst incorporated into an inexpensive and plentiful biopolymer obtained from shellfish. The biopolymer serves to stabilize the catalyst locking it into the biopolymer matrix thus preventing its leaching into the wound. Once the metal ion-biopolymer composite comes in contact with wounds, it interacts with compounds naturally found in wound fluids converting them to nitric oxide thus preventing infections and accelerating wound healing. This technology is targeted to patients with chronic diseases such as diabetes where wound healing is severely retarded or attenuated resulting in increased chances of infection and long recovery times. The other targeted group is patients suffering from pressure ulcers, especially the aging population whereby the aging process has caused structural changes in the epidermis resulting in slow wound healing. Our technology provides an inexpensive way to incorporate NO-releasing capability to bandages. These bandages will promote wound healing and prevent bacterial infections in target-patient populations decreasing recovery time, minimizing medical complications, lowering healthcare costs and increasing the quality of life of the patients. Global wound care market is growing, with an estimated CAGR of 9.5% during 2011 to 2016. Total revenues from skin ulcer segment in the wound care market are expected to reach $8.74 billion in 2016.
University of Windsor - $14,873 Grant (2015-16) | Canada Spends